A data analysis found the inhaled therapy Tyvaso outperformed a placebo at preserving lung function in people with IPF in a ...
A critically ill 33-year-old man survived an almost unimaginable scenario—living for 48 hours without lungs—thanks to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results